|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | +2.04% |
|
-1.96% | +9.89% |
| 14/07 | PharmaCorp to Seek Acquisition Opportunities | CI |
| 14/07 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.52Cr | -7.09% | - | - | - | -6.35x | |
| 1.05TCr | 7.32% | 5.37% | 9.32% | 7.03% | -7.43x | |
| 702.77Cr | 4.99% | 7.6% | 10.5% | 12.24% | -1.07x | |
| 349.32Cr | 6.87% | 10.04% | 14.98% | 6.06% | -1.29x | |
| 272.25Cr | 8.14% | 9.08% | 30.3% | 12.4% | 0.71x | |
| 393.2Cr | 4.49% | 7.41% | 17.16% | 4.67% | -0.84x | |
| 270.7Cr | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | |
| 733.86Cr | 3.55% | 6.24% | 17.17% | - | -0.31x | |
| 144.87Cr | 3.4% | 5.02% | - | - | - | |
| 345.3Cr | -1.28% | -0.41% | -7.99% | -3.4% | 5.65x | |
| 269.26Cr | 2.29% | 4.33% | 17.95% | 4.87% | 1.97x | |
| 247.86Cr | 1.52% | 2.44% | 3.57% | 3.39% | -1.3x | |
| 179.62Cr | 4.78% | 6.95% | 23.35% | 6.29% | 2.51x | |
| 74Cr | 3.19% | 4.71% | 11.82% | - | -1.01x | |
| 78Cr | 3.17% | 4.21% | 31.35% | - | 0.65x | |
| 137.66Cr | 3.52% | 4.81% | 14.2% | 8.21% | 1.77x | |
| Average | 328.13Cr | 3.48% | 5.84% | 17.35% | 6.97% | -0.46x | |
| Weighted average by Cap. | 601.71Cr | 5.56% | 6.46% | 15.61% | 7.99% | -2.56x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
